Euroapi S.A.
EAPIF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$80.68M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $80.68 Million |
|---|---|
| Enterprise Value | $337.68 Million |
| Earnings per Share | $-2.23 |
| Beta | 0.98 |
| Outstanding Shares | 94,700,000 |
Return
| Return on Equity | -67.12% |
|---|---|
| Return on Assets | -36.12% |
| Return on Invested Capital | -9.99% |
Valuation & Multiples
| P/E Ratio | -0.23 |
|---|---|
| PEG | -0.06 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.12 |
| Enterprise Value to Revenue | 0.2 |
| Enterprise Value to EBIT | -3.83 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.92 |
| Debt to Equity | 0.46 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$412.51 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 9, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Euroapi S.A.
3,133 employees
CEO: David Seignolle
Established in 2021 and headquartered in Paris, France, Euroapi SA specializes in the end-to-end process, from development and manufacturing to marketing and distribution, of active pharmaceutical ingredients (APIs) and various intermedi...